127 related articles for article (PubMed ID: 16822296)
1. Aberrant maspin expression in human endometrial cancer.
Murai S; Maesawa C; Masuda T; Sugiyama T
Cancer Sci; 2006 Sep; 97(9):883-8. PubMed ID: 16822296
[TBL] [Abstract][Full Text] [Related]
2. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells.
Akiyama Y; Maesawa C; Ogasawara S; Terashima M; Masuda T
Am J Pathol; 2003 Nov; 163(5):1911-9. PubMed ID: 14578190
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells.
Wada K; Maesawa C; Akasaka T; Masuda T
J Invest Dermatol; 2004 Mar; 122(3):805-11. PubMed ID: 15086568
[TBL] [Abstract][Full Text] [Related]
4. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.
Ogasawara S; Maesawa C; Yamamoto M; Akiyama Y; Wada K; Fujisawa K; Higuchi T; Tomisawa Y; Sato N; Endo S; Saito K; Masuda T
Oncogene; 2004 Feb; 23(5):1117-24. PubMed ID: 14743202
[TBL] [Abstract][Full Text] [Related]
5. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
8. Expression of maspin in endometrioid adenocarcinoma of endometrium.
Li HW; Leung SW; Chan CS; Yu MM; Wong YF
Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of maspin gene expression in human breast cancers.
Domann FE; Rice JC; Hendrix MJ; Futscher BW
Int J Cancer; 2000 Mar; 85(6):805-10. PubMed ID: 10709100
[TBL] [Abstract][Full Text] [Related]
10. Expression and regulation of tumor suppressor gene maspin in human bladder cancer.
Sugimoto S; Maass N; Takimoto Y; Sato K; Minei S; Zhang M; Hoshikawa Y; Jünemann KP; Jonat W; Nagasaki K
Cancer Lett; 2004 Jan; 203(2):209-15. PubMed ID: 14732229
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Tumour Biol; 2011 Feb; 32(1):23-32. PubMed ID: 20697987
[TBL] [Abstract][Full Text] [Related]
12. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
[TBL] [Abstract][Full Text] [Related]
13. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas.
Fujisawa K; Maesawa C; Sato R; Wada K; Ogasawara S; Akiyama Y; Takeda M; Fujita T; Otsuka K; Higuchi T; Suzuki K; Saito K; Masuda T
Lab Invest; 2005 Feb; 85(2):214-24. PubMed ID: 15608662
[TBL] [Abstract][Full Text] [Related]
15. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality.
Ito R; Nakayama H; Yoshida K; Oda N; Yasui W
Oncol Rep; 2004 Nov; 12(5):985-90. PubMed ID: 15492782
[TBL] [Abstract][Full Text] [Related]
16. Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: a preliminary report.
Torres A; Torres K; Paszkowski T; Radej S; Staśkiewicz GJ; Ceccaroni M; Pesci A; Maciejewski R
Int J Gynecol Cancer; 2011 Jan; 21(1):8-14. PubMed ID: 21330826
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
[TBL] [Abstract][Full Text] [Related]
18. [Transcription regulation of 5-Aza-2'-deoxycytidine on maspin gene demethylation in RKO human colorectal cell line].
Tang B; Peng ZH; Yu PW; Zeng DZ; Zhang C
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):260-3. PubMed ID: 16721693
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas.
Ohike N; Maass N; Mundhenke C; Biallek M; Zhang M; Jonat W; Lüttges J; Morohoshi T; Klöppel G; Nagasaki K
Cancer Lett; 2003 Sep; 199(2):193-200. PubMed ID: 12969792
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
